Publications by authors named "Kimberly M Sorensen"
Article Synopsis
- Ceftaroline fosamil is FDA-approved for treating acute bacterial skin infections and community-acquired pneumonia, but its real-world usage and safety profiles in veterans are not well understood.
- A study conducted in 69 VHA hospitals analyzed data from 764 predominantly male patients (97%) with an average age of 61, highlighting a range of infections treated with ceftaroline, including skin (40%) and sepsis (30%).
- Results showed a low all-cause in-hospital mortality rate (5%), aligning closely with clinical trial findings, indicating that ceftaroline is effectively managing infections with minimal adverse effects among veterans.
